基于监管要求的临床试验元数据审核实操指南OA
A Practical Guide to Metadata Review in Clinical Trials for Regulatory Compliance
随着全球临床试验监管体系持续完善,元数据作为保障数据全生命周期可追溯、可验证的核心载体,其审核质量直接影响试验数据可靠性与监管认可度.针对当前行业存在的元数据定义不统一、盲态保护不完善、第三方管理薄弱、技术工具适配不足等问题,本研究参考《E6(R3):药物临床试验质量管理规范技术指导原则》《药物临床试验计算机化系统和电子数据指导原则(征求意见稿)》等国内外相关要求,结合临床实操经验,系统构建了兼具合规性与实操性的临床试验元数据审核框架.研究明确了技术元数据、过程元数据、业务元数据的核心范畴与临床价值,确立"范围全覆盖、内容全维度、对象分风险、实施全流程"4大审核原则,细化了数据采集、处理、传输、存储、归档、销毁全生命周期的审核要点,制定盲态数据的元数据审核专项方案、第三方管理机制及工具选型标准,并针对行业痛点提出标准化体系建设、技术工具升级、人员能力提升等优化对策.该框架为临床试验元数据审核提供了标准化实操参考,可有效提升数据质量与审核效率,降低监管核查风险,助力临床试验数据治理与国际监管要求接轨.
With the continuous evolution of global regulatory requirements for clinical trials,metadata has become a core element for ensuring the traceability and verifiability of data throughout its lifecycle.The quality of metadata review directly affects the reliability of trial data and its acceptance by regulatory authorities.In response to common industry challenges,such as inconsistent metadata definitions,inadequate blinding protection,weak third-party management,and insufficient adaptation of technical tools,this study systematically constructs a compliant and practice-oriented metadata review framework for clinical trials.The framework is grounded in both international and domestic regulatory requirements,including ICH GCP E6(R3)and China's Guidelines for Computerized Systems and Electronic Data in Clinical Trials(Draft),and is informed by real-world operational experience.The study clarifies the core scope and clinical value of technical,process,and business metadata,and establishes four key review principles:full-scope coverage,multidimensional content,risk-based object classification,and lifecycle-wide implementation.It further elaborates review focus areas across the entire data lifecycle(collection,processing,transformation,storage,archiving,and destruction).In addition,it proposes dedicated metadata review plan for blinded data,third-party management,and tool selection,and puts forward optimization strategies targeting key industry challenges,such as standardized system development,technological enhancement,and workforce capacity building.This framework provides a standardized and practical reference for metadata review in clinical trials,contributing to improved data quality and review efficiency,reduced regulatory inspection risks,and better alignment of clinical trial data governance with international regulatory expectations.
颜崇超
江苏恒瑞医药生物计量部临床数据科学中心
医药卫生
元数据审核数据完整性盲态保护数据全生命周期监管合规
metadata reviewdata integrityblindingdata lifecycleregulatory compliance
《中国食品药品监管》 2026 (4)
104-123,20
评论